Collectively, these results demonstrated targeting CD103+ TRM cells could not mitigate CS-induced pulmonary fibrosis, which was related to the expansion of TRM-Teff cells (CD103– TRM). This evidence concerns the gene ITGAE and pulmonary fibrosis.